Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer

Anaís Sánchez-Castillo; Elien Heylen; Judith Hounjet; Kim G Savelkouls; Natasja G Lieuwes; Rianne Biemans; Ludwig J Dubois; Kobe Reynders; Kasper M Rouschop; Rianne D W Vaes; Kim De Keersmaecker; Maarten Lambrecht; Lizza E L Hendriks; Dirk K M De Ruysscher; Marc Vooijs; Kim R Kampen

doi:10.1038/s41416-024-02603-z

Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer

Anaís Sánchez-Castillo, Elien Heylen, Judith Hounjet, Kim G Savelkouls, Natasja G Lieuwes, Rianne Biemans, Ludwig J Dubois, Kobe Reynders, Kasper M Rouschop, Rianne D W Vaes, Kim De Keersmaecker, Maarten Lambrecht, Lizza E L Hendriks, Dirk K M De Ruysscher, Marc Vooijs, Kim R Kampen^*

^*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Abstract

Correction to: British Journal of Cancerhttps://doi.org/10.1038/s41416-023-02553-y, published online 30 December 2023 In this article the funding section has been omitted during the production process. It should read: Funding information ASC received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No # 860245 (to MV). E.H. was supported by an aspirant FWO fellowship 1106119N. KRK received funding to perform metabolomics mass spectrometry analysis, which was funded by a research grant from FWO (FWO KAN2018 871 1501419N), further experiments were supported by the KNAW early career award 2022 and FEBS excellence award 2022 (to KRK). The original article has been corrected.

Original language	English
Article number	701
Number of pages	1
Journal	British Journal of Cancer
Volume	130
Issue number	4
DOIs	https://doi.org/10.1038/s41416-024-02603-z
Publication status	Published - 9 Mar 2024

Access to Document

10.1038/s41416-024-02603-zLicence: CC BY

1 Article

Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer
Sanchez-Castillo, A., Heylen, E., Hounjet, J., Savelkouls, K. G., Lieuwes, N. G., Biemans, R., Dubois, L. J., Reynders, K., Rouschop, K. M., Vaes, R. D. W., De Keersmaecker, K., Lambrecht, M., Hendriks, L. E. L., De Ruysscher, D. K. M., Vooijs, M. & Kampen, K. R., 9 Mar 2024, In: British Journal of Cancer. 130, 4, p. 568-584 17 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Cite this

Sánchez-Castillo, A., Heylen, E., Hounjet, J., Savelkouls, K. G., Lieuwes, N. G., Biemans, R., Dubois, L. J., Reynders, K., Rouschop, K. M., Vaes, R. D. W., De Keersmaecker, K., Lambrecht, M., Hendriks, L. E. L., De Ruysscher, D. K. M., Vooijs, M., & Kampen, K. R. (2024). Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer. British Journal of Cancer, 130(4), Article 701. https://doi.org/10.1038/s41416-024-02603-z

@article{704b2bf1e31142c9a2b315f0b34c9de0,

title = "Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer",

abstract = "Correction to: British Journal of Cancerhttps://doi.org/10.1038/s41416-023-02553-y, published online 30 December 2023 In this article the funding section has been omitted during the production process. It should read: Funding information ASC received funding from the European Union{\textquoteright}s Horizon 2020 research and innovation programme under the Marie Sk{\l}odowska-Curie grant agreement No # 860245 (to MV). E.H. was supported by an aspirant FWO fellowship 1106119N. KRK received funding to perform metabolomics mass spectrometry analysis, which was funded by a research grant from FWO (FWO KAN2018 871 1501419N), further experiments were supported by the KNAW early career award 2022 and FEBS excellence award 2022 (to KRK). The original article has been corrected.",

author = "Ana{\'i}s S{\'a}nchez-Castillo and Elien Heylen and Judith Hounjet and Savelkouls, {Kim G} and Lieuwes, {Natasja G} and Rianne Biemans and Dubois, {Ludwig J} and Kobe Reynders and Rouschop, {Kasper M} and Vaes, {Rianne D W} and {De Keersmaecker}, Kim and Maarten Lambrecht and Hendriks, {Lizza E L} and {De Ruysscher}, {Dirk K M} and Marc Vooijs and Kampen, {Kim R}",

year = "2024",

month = mar,

day = "9",

doi = "10.1038/s41416-024-02603-z",

language = "English",

volume = "130",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "4",

}

Sánchez-Castillo, A, Heylen, E, Hounjet, J , Savelkouls, KG , Lieuwes, NG, Biemans, R, Dubois, LJ, Reynders, K, Rouschop, KM, Vaes, RDW, De Keersmaecker, K, Lambrecht, M, Hendriks, LEL , De Ruysscher, DKM , Vooijs, M & Kampen, KR 2024, 'Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer', British Journal of Cancer, vol. 130, no. 4, 701. https://doi.org/10.1038/s41416-024-02603-z

TY - JOUR

T1 - Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer

AU - Sánchez-Castillo, Anaís

AU - Heylen, Elien

AU - Hounjet, Judith

AU - Savelkouls, Kim G

AU - Lieuwes, Natasja G

AU - Biemans, Rianne

AU - Dubois, Ludwig J

AU - Reynders, Kobe

AU - Rouschop, Kasper M

AU - Vaes, Rianne D W

AU - De Keersmaecker, Kim

AU - Lambrecht, Maarten

AU - Hendriks, Lizza E L

AU - De Ruysscher, Dirk K M

AU - Vooijs, Marc

AU - Kampen, Kim R

PY - 2024/3/9

Y1 - 2024/3/9

N2 - Correction to: British Journal of Cancerhttps://doi.org/10.1038/s41416-023-02553-y, published online 30 December 2023 In this article the funding section has been omitted during the production process. It should read: Funding information ASC received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No # 860245 (to MV). E.H. was supported by an aspirant FWO fellowship 1106119N. KRK received funding to perform metabolomics mass spectrometry analysis, which was funded by a research grant from FWO (FWO KAN2018 871 1501419N), further experiments were supported by the KNAW early career award 2022 and FEBS excellence award 2022 (to KRK). The original article has been corrected.

AB - Correction to: British Journal of Cancerhttps://doi.org/10.1038/s41416-023-02553-y, published online 30 December 2023 In this article the funding section has been omitted during the production process. It should read: Funding information ASC received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No # 860245 (to MV). E.H. was supported by an aspirant FWO fellowship 1106119N. KRK received funding to perform metabolomics mass spectrometry analysis, which was funded by a research grant from FWO (FWO KAN2018 871 1501419N), further experiments were supported by the KNAW early career award 2022 and FEBS excellence award 2022 (to KRK). The original article has been corrected.

U2 - 10.1038/s41416-024-02603-z

DO - 10.1038/s41416-024-02603-z

M3 - Erratum / corrigendum / retractions

SN - 0007-0920

VL - 130

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 4

M1 - 701

ER -

Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer

Abstract

Access to Document

Fingerprint

Research output

Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer

Cite this